메뉴 건너뛰기




Volumn 362, Issue 9387, 2003, Pages 859-868

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-Month follow-up of the HIVNET 012 randomised trial

(22)  Jackson, J Brooks a   Musoke, Philippa b   Fleming, Thomas c,d   Guay, Laura A a   Bagenda, Danstan b   Allen, Melissa e   Nakabiito, Clemensia b   Sherman, Joseph a   Bakaki, Paul b   Owor, Maxensia b   Ducar, Constance a   Deseyve, Martina d   Mwatha, Anthony d   Emel, Lynda d   Duefield, Corey a   Mirochnick, Mark f   Fowler, Mary Glenn g   Mofenson, Lynne h   Miotti, Paolo g   Gigliotti, Maria i   more..


Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

EID: 0141518673     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14341-3     Document Type: Article
Times cited : (437)

References (34)
  • 1
    • 36549011407 scopus 로고    scopus 로고
    • Geneva UNAIDS-WHO
    • UNAIDS. AIDS epidemic update, December, 2002. Geneva UNAIDS-WHO, 2002. http://www.unaids.org/worldaidsday/2002/press/Epiupdate.html (accessed March 6, 2003).
    • (2002) AIDS Epidemic Update, December, 2002
  • 2
    • 0028003766 scopus 로고
    • Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
    • Connor E., Sperling R., Gelber R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 331:1994;1173-1180.
    • (1994) N Engl J Med , vol.331 , pp. 1173-1180
    • Connor, E.1    Sperling, R.2    Gelber, R.3
  • 3
    • 0029558404 scopus 로고
    • Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of a Markov model: The HIV Infection in Newborns French Collaborative Study Group
    • Rouzioux C., Costagliola D., Burgard M., et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of a Markov model: the HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol. 142:1995;1330-1337.
    • (1995) Am J Epidemiol , vol.142 , pp. 1330-1337
    • Rouzioux, C.1    Costagliola, D.2    Burgard, M.3
  • 4
    • 19244362947 scopus 로고    scopus 로고
    • Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast feeding population in Kinshasha, Zaire
    • Bertolli J., St Louis M.E., Simonds R.J., et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast feeding population in Kinshasha, Zaire. J Infect Dis. 174:1996;722-726.
    • (1996) J Infect Dis , vol.174 , pp. 722-726
    • Bertolli, J.1    St Louis, M.E.2    Simonds, R.J.3
  • 5
    • 0033528527 scopus 로고    scopus 로고
    • Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial
    • Wiktor S.Z., Ekpini E., Karon J.M., et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet. 353:1999;781-785.
    • (1999) Lancet , vol.353 , pp. 781-785
    • Wiktor, S.Z.1    Ekpini, E.2    Karon, J.M.3
  • 6
    • 0033528521 scopus 로고    scopus 로고
    • 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: A double-blind placebo-controlled multicentre trial
    • Dabis F., Msellati P., Meda N., et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet. 353:1999;786-792.
    • (1999) Lancet , vol.353 , pp. 786-792
    • Dabis, F.1    Msellati, P.2    Meda, N.3
  • 7
    • 0033528520 scopus 로고    scopus 로고
    • Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
    • Shaffer N., Chuachoowong R., Mock P.A., et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 353:1999;773-780.
    • (1999) Lancet , vol.353 , pp. 773-780
    • Shaffer, N.1    Chuachoowong, R.2    Mock, P.A.3
  • 8
    • 0032511919 scopus 로고    scopus 로고
    • Mother-to-child transmission of HIV: Implications of variation in maternal infectivity
    • Dunn D.T., Tess B.H., Rodrigues L.C., Ades A.E. Mother-to-child transmission of HIV: implications of variation in maternal infectivity. AIDS. 12:1998;2211-2216.
    • (1998) AIDS , vol.12 , pp. 2211-2216
    • Dunn, D.T.1    Tess, B.H.2    Rodrigues, L.C.3    Ades, A.E.4
  • 9
    • 0032558333 scopus 로고    scopus 로고
    • International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection
    • Leroy V., Newell M.L., Dabis F., et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet. 352:1998;597-600.
    • (1998) Lancet , vol.352 , pp. 597-600
    • Leroy, V.1    Newell, M.L.2    Dabis, F.3
  • 10
    • 0033603802 scopus 로고    scopus 로고
    • HIV transmission from breastfeeding: A study in Malawi
    • Miotti P.G., Taha T.E.T., Kumwenda N.I., et al. HIV transmission from breastfeeding: a study in Malawi. JAMA. 282:1999;744-749.
    • (1999) JAMA , vol.282 , pp. 744-749
    • Miotti, P.G.1    Taha, T.E.T.2    Kumwenda, N.I.3
  • 11
    • 10544245018 scopus 로고    scopus 로고
    • Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
    • Sperling R.S., Shapiro D.E., Coombs R.W., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Eng J Med. 335:1998;1621-1629.
    • (1998) N Eng J Med , vol.335 , pp. 1621-1629
    • Sperling, R.S.1    Shapiro, D.E.2    Coombs, R.W.3
  • 12
    • 0033523454 scopus 로고    scopus 로고
    • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
    • Guay L., Musoke P., Fleming T., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 354:1999;795-802.
    • (1999) Lancet , vol.354 , pp. 795-802
    • Guay, L.1    Musoke, P.2    Fleming, T.3
  • 13
    • 0018687930 scopus 로고
    • A multi-stage procedure for clinical trials
    • O'Brien P.C., Fleming T.R. A multi-stage procedure for clinical trials. Biometrics. 35:1979;549-556.
    • (1979) Biometrics , vol.35 , pp. 549-556
    • O'Brien, P.C.1    Fleming, T.R.2
  • 14
    • 0032419597 scopus 로고    scopus 로고
    • Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection
    • Pollard R.B., Robinson P., Dransfield K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther. 20:1998;1071-1092.
    • (1998) Clin Ther , vol.20 , pp. 1071-1092
    • Pollard, R.B.1    Robinson, P.2    Dransfield, K.3
  • 15
    • 0034614136 scopus 로고    scopus 로고
    • Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers
    • Sha B.E., Proia L., Kessler H.A. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA. 284:2000;2723-2724.
    • (2000) JAMA , vol.284 , pp. 2723-2724
    • Sha, B.E.1    Proia, L.2    Kessler, H.A.3
  • 16
    • 0035799102 scopus 로고    scopus 로고
    • Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1
    • Benn P.D., Mercey D.E., Brink N., Scott G., William I.G. Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1. Lancet. 357:2001;687-688.
    • (2001) Lancet , vol.357 , pp. 687-688
    • Benn, P.D.1    Mercey, D.E.2    Brink, N.3    Scott, G.4    William, I.G.5
  • 17
    • 0000544290 scopus 로고    scopus 로고
    • Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - Worldwide, 1997-2000
    • Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep. 49:2001;1153-1156.
    • (2001) MMWR Morb Mortal Wkly Rep , vol.49 , pp. 1153-1156
  • 18
    • 17344368990 scopus 로고    scopus 로고
    • Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates
    • Mirochnick M., Fenton T., Gagnier P., et al. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. J Infect Dis. 178:1998;368-374.
    • (1998) J Infect Dis , vol.178 , pp. 368-374
    • Mirochnick, M.1    Fenton, T.2    Gagnier, P.3
  • 19
    • 0033545463 scopus 로고    scopus 로고
    • A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected Ugandan women and their neonates (HIVNET 006)
    • Musoke P., Guay L., Bagenda D., et al. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected Ugandan women and their neonates (HIVNET 006). AIDS. 13:1999;479-486.
    • (1999) AIDS , vol.13 , pp. 479-486
    • Musoke, P.1    Guay, L.2    Bagenda, D.3
  • 20
    • 0037055088 scopus 로고    scopus 로고
    • Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial
    • Dorenbaum A., Cunningham C.K., Gelber R.D., et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 288:2002;189-198.
    • (2002) JAMA , vol.288 , pp. 189-198
    • Dorenbaum, A.1    Cunningham, C.K.2    Gelber, R.D.3
  • 21
    • 0037333802 scopus 로고    scopus 로고
    • A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1
    • Moodley D., Moodley J., Coovadia H., et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 187:2003;725-735.
    • (2003) J Infect Dis , vol.187 , pp. 725-735
    • Moodley, D.1    Moodley, J.2    Coovadia, H.3
  • 22
    • 0037029419 scopus 로고    scopus 로고
    • Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania,South Africa, and Uganda (Petra study): A randomised, double blind, placebo-controlled trial
    • Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania,South Africa, and Uganda (Petra study): a randomised, double blind, placebo-controlled trial. Lancet. 359:2002;1178-1186.
    • (2002) Lancet , vol.359 , pp. 1178-1186
  • 23
    • 0032511952 scopus 로고    scopus 로고
    • Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus
    • Wade N.A., Birkhead G.S., Warren B. L., et al. Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus. N Engl J Med. 339:1998;1409-1414.
    • (1998) N Engl J Med , vol.339 , pp. 1409-1414
    • Wade, N.A.1    Birkhead, G.S.2    Warren B., L.3
  • 24
    • 0037159519 scopus 로고    scopus 로고
    • US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States
    • US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Wkly Rep. 51:2002;1-40. http://AIDSInfo.nih.gov accessed March 6, 2003.
    • (2002) MMWR Morb Mortal Wkly Rep , vol.51 , pp. 1-40
  • 25
    • 0036239507 scopus 로고    scopus 로고
    • Effectiveness of potent antiretroviral therapies onreducing perinatal transmission of HIV-1
    • Cooper E., Charurat M., Mofenson L., et al. Effectiveness of potent antiretroviral therapies onreducing perinatal transmission of HIV-1. J Acquir Immune Defic Syndr Human Retrovirol. 29:2002;484-494.
    • (2002) J Acquir Immune Defic Syndr Human Retrovirol , vol.29 , pp. 484-494
    • Cooper, E.1    Charurat, M.2    Mofenson, L.3
  • 26
    • 0034161409 scopus 로고    scopus 로고
    • Effect of breast feeding and formula feeding on transmission of HIV-1
    • Nduati R., John G., Mbori-Ngacha D., et al. Effect of breast feeding and formula feeding on transmission of HIV-1. JAMA. 283:2000;1167-1174.
    • (2000) JAMA , vol.283 , pp. 1167-1174
    • Nduati, R.1    John, G.2    Mbori-Ngacha, D.3
  • 27
    • 0035895633 scopus 로고    scopus 로고
    • Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: Prospective cohort study from Durban, South Africa
    • Coutsoudis A., Pillay K., Kuhn L., et al. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 15:2001;379-387.
    • (2001) AIDS , vol.15 , pp. 379-387
    • Coutsoudis, A.1    Pillay, K.2    Kuhn, L.3
  • 28
    • 0033816265 scopus 로고    scopus 로고
    • Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
    • Jackson J.B., Becker-Pergola G., Guay L., et al. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS. 14:2000;F111-F115.
    • (2000) AIDS , vol.14
    • Jackson, J.B.1    Becker-Pergola, G.2    Guay, L.3
  • 29
    • 0035913939 scopus 로고    scopus 로고
    • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
    • Eshleman S.H., Mracna M., Guay L.A., et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS. 15:2001;1951-1957.
    • (2001) AIDS , vol.15 , pp. 1951-1957
    • Eshleman, S.H.1    Mracna, M.2    Guay, L.A.3
  • 30
    • 0033523387 scopus 로고    scopus 로고
    • The cost-effectiveness of a single dose nevirapine regimen to mother and infant to reduce vertical HIV transmission in Uganda
    • Marseille E., Kahn J., Mmiro F., et al. The cost-effectiveness of a single dose nevirapine regimen to mother and infant to reduce vertical HIV transmission in Uganda. Lancet. 354:1999;803-809.
    • (1999) Lancet , vol.354 , pp. 803-809
    • Marseille, E.1    Kahn, J.2    Mmiro, F.3
  • 32
    • 85031081677 scopus 로고    scopus 로고
    • Protocol MPH NEV-7: Prevention of the mother-to-child transmission of HIV
    • Durban, South Africa, July: abstr LbPeC7086
    • Sousselier M, Sousselier B, Arouko H. Protocol MPH NEV-7: prevention of the mother-to-child transmission of HIV. XIII International AIDS Conference, Durban, South Africa, July 2000: abstr LbPeC7086.
    • (2000) XIII International AIDS Conference
    • Sousselier, M.1    Sousselier, B.2    Arouko, H.3
  • 33
    • 0037446414 scopus 로고    scopus 로고
    • Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings
    • Stringer J.S.A., Sinkala M., Stout J.P., et al. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. JAcquir Immune Defic Syndr. 32:2003;506-513.
    • (2003) JAcquir Immune Defic Syndr , vol.32 , pp. 506-513
    • Stringer, J.S.A.1    Sinkala, M.2    Stout, J.P.3
  • 34
    • 0043129064 scopus 로고    scopus 로고
    • Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine
    • Stringer J.S.A., Sinkala M., Chapman V., et al. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS. 17:2003;1659-1665.
    • (2003) AIDS , vol.17 , pp. 1659-1665
    • Stringer, J.S.A.1    Sinkala, M.2    Chapman, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.